These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 6088394

  • 1. In vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor.
    Meade BD, Kind PD, Ewell JB, McGrath PP, Manclark CR.
    Infect Immun; 1984 Sep; 45(3):718-25. PubMed ID: 6088394
    [Abstract] [Full Text] [Related]

  • 2. Altered mononuclear phagocyte function in mice treated with the lymphocytosis promoting factor of Bordetella pertussis.
    Meade BD, Kind PD, Manclark CR.
    Dev Biol Stand; 1985 Sep; 61():63-74. PubMed ID: 2872133
    [Abstract] [Full Text] [Related]

  • 3. Lymphocytosis-promoting factor of Bordetella pertussis alters mononuclear phagocyte circulation and response to inflammation.
    Meade BD, Kind PD, Manclark CR.
    Infect Immun; 1984 Dec; 46(3):733-9. PubMed ID: 6094357
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
    Robinson A, Irons LI.
    Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
    [Abstract] [Full Text] [Related]

  • 5. Effect of Bordetella pertussis leukocytosis (lymphocytosis)-promoting factor (LPF) on the physical lymphoepithelial-cell association studied with the use of an in vitro model of mouse thymus.
    Sugimoto M, Nakanishi Y, Otokawa M, Uchida N, Yasuda T, Sato H, Sato Y.
    J Immunol; 1983 Jun; 130(6):2767-74. PubMed ID: 6682875
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The mitogenic effect of the lymphocytosis promoting factor from Bordetella pertussis on human T gamma and non-T gamma cells.
    Kashiwa H, Hyodo S, Kishi T, Karakawa T, Kittaka E, Suzawa T, Sakano T, Usui T.
    Clin Exp Immunol; 1984 Nov; 58(2):436-43. PubMed ID: 6094059
    [Abstract] [Full Text] [Related]

  • 8. Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.
    Robinson A, Hawkins DC.
    Infect Immun; 1983 Feb; 39(2):590-8. PubMed ID: 6299946
    [Abstract] [Full Text] [Related]

  • 9. The in vitro effects of Bordetella pertussis lymphocytosis-promoting factor on murine lymphocytes: II. Nature of the responding cells.
    Kong AS, Morse SI.
    J Exp Med; 1977 Jan 01; 145(1):163-74. PubMed ID: 187716
    [Abstract] [Full Text] [Related]

  • 10. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR.
    Infect Immun; 1983 Jul 01; 41(1):313-20. PubMed ID: 6305841
    [Abstract] [Full Text] [Related]

  • 11. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
    Oda M, Cowell JL, Burstyn DG, Manclark CR.
    J Infect Dis; 1984 Dec 01; 150(6):823-33. PubMed ID: 6094673
    [Abstract] [Full Text] [Related]

  • 12. Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis.
    Sato Y, Izumiya K, Sato H, Cowell JL, Manclark CR.
    Infect Immun; 1981 Mar 01; 31(3):1223-31. PubMed ID: 6262248
    [Abstract] [Full Text] [Related]

  • 13. The effect of Bordetella pertussis lymphocytosis-promoting factor (LPF) on antibody response in mice: its enhancing and suppressive effects.
    Asakawa S, Iwasa S.
    Jpn J Med Sci Biol; 1982 Feb 01; 35(1):25-9. PubMed ID: 6285047
    [Abstract] [Full Text] [Related]

  • 14. Effect of lymphocytosis-promoting factor from Bordetella pertussis on cerebellar cyclic GMP levels.
    Askelöf P, Gillenius P.
    Infect Immun; 1982 Jun 01; 36(3):958-61. PubMed ID: 6284647
    [Abstract] [Full Text] [Related]

  • 15. Delayed type hypersensitivity induced by LPF from Bordetella pertussis.
    Guadalupe Cortés JM, Juliano Y, Mendes NF, Mendes E.
    Allergol Immunopathol (Madr); 1986 Jun 01; 14(4):311-7. PubMed ID: 2877558
    [Abstract] [Full Text] [Related]

  • 16. Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.
    Morse SI, Morse JH.
    J Exp Med; 1976 Jun 01; 143(6):1483-502. PubMed ID: 58054
    [Abstract] [Full Text] [Related]

  • 17. Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines.
    Tiru M, Jäätmaa E, Gillenius P, Askelöf P.
    Dev Biol Stand; 1985 Jun 01; 61():469-75. PubMed ID: 2872128
    [Abstract] [Full Text] [Related]

  • 18. Role of immune sera in the in-vitro phagocytosis of Bordetella pertussis strains.
    Stefanelli P, Ippoliti R, Fazio C, Mastrantonio P.
    Microb Pathog; 2002 Mar 01; 32(3):135-41. PubMed ID: 11855944
    [Abstract] [Full Text] [Related]

  • 19. Effect of betamethasone in lungs of mice treated with lymphocytosis-promoting factor of Bordetella pertussis.
    Torre D, Quadrelli C, Pugliese A, Maggiolo F.
    J Infect Dis; 1986 Aug 01; 154(2):238-44. PubMed ID: 3722864
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of monocyte oxidative responses by Bordetella pertussis adenylate cyclase toxin.
    Pearson RD, Symes P, Conboy M, Weiss AA, Hewlett EL.
    J Immunol; 1987 Oct 15; 139(8):2749-54. PubMed ID: 2888823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.